P. Jacobi

发表

Mutations in the D'D3 region of VWF traditionally associated with type 1 VWD lead to quantitative and qualitative deficiencies of VWF.

J. Di Paola, C. Ng, S. Haberichter, 2016, Thrombosis research.

Reduced von Willebrand factor secretion is associated with loss of Weibel–Palade body formation

F. Rodeghiero, G. Castaman, R. Schneppenheim, 2012, Journal of thrombosis and haemostasis : JTH.

Homozygous type 2N R854W von Willebrand factor is poorly secreted and causes a severe von Willebrand disease phenotype

F. Rodeghiero, G. Castaman, R. Schneppenheim, 2010, Journal of thrombosis and haemostasis : JTH.

From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 22, 2013. For personal use

R. Montgomery, S. Haberichter, P. Jacobi, 2002 .

Genetic variants in ADAMTS13 as well as smoking are major determinants of plasma ADAMTS13 levels.

Jun Z. Li, C. Kimchi-Sarfaty, Brian T. Emmer, 2017, Blood advances.

Downregulation of thrombomodulin-thrombin-activated protein C pathway as a mechanism for SARS-CoV-2 induced endotheliopathy and microvascular thrombosis

P. Jacobi, C. Cohen, S. Sartain, 2022, Thrombosis Update.

Neuropeptide FF Receptors Have Opposing Modulatory Effects on Nociception

J. Lameh, R. Olsson, Derek Nguyen, 2010, Journal of Pharmacology and Experimental Therapeutics.

Collagen binding provides a sensitive screen for variant von Willebrand disease.

R. Hoffmann, R. Montgomery, J. Gill, 2013, Clinical chemistry.

Crucial role for the VWF A1 domain in binding to type IV collagen.

D. Bellissimo, R. Hoffmann, R. Montgomery, 2015, Blood.

Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A

K. Cornetta, P. Nurden, Troy B. Hawkins, 2013, Nature Communications.

Platelet-Targeted Expression of Human BDD-FVIII Reduces Bleeding in Canine Hemophilia A.

T. Nichols, R. Montgomery, Juan Fang, 2009 .

Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storage.

J. Gill, K. Friedman, S. Haberichter, 2012, Blood.

Variable content of von Willebrand factor mutant monomer drives the phenotypic variability in a family with von Willebrand disease.

Junmei Chen, R. Montgomery, Jesse Hinckley, 2015, Blood.

Whole exome sequencing identifies rare variants in STAB2 associated with venous thromboembolic disease.

D. Goldstein, Jun Z. Li, P. Reitsma, 2020, Blood.

Genome‐wide studies of von Willebrand factor propeptide identify loci contributing to variation in propeptide levels and von Willebrand factor clearance

L. Brody, J. Mills, D. Ginsburg, 2016, Journal of thrombosis and haemostasis : JTH.

Genom e-wide stud ies of von Willebrand Factor Propeptide I dentify Loci Contributing to Variation in Propeptide Levels and von Willebrand Factor

L. Brody, J. Mills, D. Ginsburg, 2016 .

THROMBOSIS AND HEMOSTASIS Crucial role for the VWF A 1 domain in binding to type IV collagen

D. Bellissimo, R. Hoffmann, R. Montgomery, 2015 .

Title: Crucial Role for the VWF A1 Domain In Binding to Type IV Collagen Short title: VWF Binds Collagen IV

D. Bellissimo, R. Hoffmann, R. Montgomery, 2015 .

Critical independent regions in the VWF propeptide and mature VWF that enable normal VWF storage.

R. Montgomery, S. Haberichter, P. Jacobi, 2003, Blood.

von Willebrand factor propeptide to antigen ratio identifies platelet activation and reduced von Willebrand factor survival phenotype in mice

J. Johnsen, S. Haberichter, P. Jacobi, 2018, Journal of Thrombosis and Haemostasis.

Exome Sequencing in Venous Thromboembolic Disease Identifies Excess Mutation Burden in PROS1, PROC, SERPINC1 and STAB2

D. Goldstein, P. Reitsma, D. Trégouët, 2016 .